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There remain some mysteries to be
solved. First, b-catenin is not required for
hematopoiesis. Whether this indepen-
dence is also true for tissue regeneration
is not known, although WNT signaling
activity may be a more pertinent criterion,
since even theb-catenin/g-catenin double
knockout mice retain WNT-reporter
activity through an unknown compensa-
tory mechanism (Jeannet et al., 2008).
Second, sustained (chronic) stimulation
of either PGE2 or WNT signaling could
potentially have the opposite effect and
deplete stem cell activity (Kirstetter et al.,
2006; Scheller et al., 2006). Therefore, it
might be appropriate in a clinical setting
to modulateb-catenin through these path-
ways, but there can be too much of
a ‘‘good thing.’’ It will be a tricky balancing
act to promote regeneration without
depletion of stem cell pools or promotion
of oncogenesis.
A second lesson provided by this study
is that elegant experimental approaches
in the zebrafish model system can be
combined in imaginative ways to reveal
mechanistic insight. The list of techniques
includes the use of reporter fish to quan-
tify in vivo signaling activities and stem
cell populations, a repertoire of trans-
genics for manipulating signaling condi-
tionally, and the use of chemical biology
to identify new probes for blocking or
enhancing pathways to establish mecha-
nism. While each of the research tools
employed here was already available,
their combined use applied across
multiple organ systems in the embryo
and the adult demonstrates a very
impressive molecular toolbox for the
zebrafish model. The relative ease of
applying chemical probes and inducible
stimuli (in this case, heat, but many others
are conceivable), combined with lineage
reporters and tissue regeneration assays,
confirm the advantage of testing compli-
cated models in fish before moving on to
confirm they are conserved in mammalian
systems. The success of Goessling et al.
in this sense bodes well for future fishing
experiments and the discovery of novel
modulators to impact both cancer and
stem cell biology.
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Articular cartilage is the target tissue of osteoarthritis (OA), a degenerative disease with no cure. In this issue
of Cell Stem Cell, Miosge and colleagues (Koelling et al., 2009) report that migratory progenitor cells occupy
degenerating OA tissue but that this population is not present in healthy cartilage.In 1740, James Douglas, physician to the
Queen of England, was involved in
a monumental study on the nature of
bones and employed the noted anatomist
William Hunter to be his dissector. Doug-
las died 2 years later, but Hunter per-
sisted, and in 1743 the results of his282 Cell Stem Cell 4, April 3, 2009 ª2009 Elobservations on the structure of articular
cartilage and its diseases were published
by the Royal Society (Hunter, 1743). Using
a glass lens, Hunter described the
unbroken, glossy smoothness of the artic-
ular surface, that ‘‘it yields to the touch,
but restores itself to its former equality ofsevier Inc.surface when the pressure is taken off.’’
He also noted, ‘‘From Hippocrates to the
present age it is universally allowed that
ulcerated cartilage is a troublesome thing
and that, once destroyed, is not re-
paired.’’ Until recently, it was considered
that, in part, cartilage’s poor reparative
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progenitor cells within the tissue and the
lack of vasculature that might deliver
stem cells to the site of local damage. In
this issue, Koelling et al. (2009) describe
the presence of previously unrecognized
migratory progenitor cells within diseased
osteoarthritic cartilage that are not de-
tected in normal healthy tissue.
Articular cartilage is an unvascularized,
aneural, and alymphatic tissue whose
singular cell source is the chondrocyte
(Muir, 1995). The tissue is sparsely popu-
lated with cells organized in a psuedostra-
tified manner consisting of three unminer-
alized layers and a mineralized calcified
layer, with the junction between the last
two zones known as the tidemark
(Figure 1A). The chondrocytes maintain
an extensive extracellular matrix whose
primary constituents are water, aggre-
gans, and type II collagen. Isolated,
encapsulated within a lacunae, and in the
presence of an all-encompassing extra-
cellular matrix, chondrocytes do not have
the capacity to migrate to the site of injury
and initiate proliferation and repair; conse-
quently, cartilage has a seemingly low
intrinsic capacity for regeneration in
mature tissue (Tew et al., 2001). Gross
changes in cellular morphology and extra-
cellular matrix composition do occur
during osteoarthritis (OA), a chronic and
degenerative joint disease that leads to
the progressive loss of articular cartilage
over a period of 10–15 years, resulting in
eburnation, the conversion of the under-
lying bone into an extremely dense and
smooth ivory-like surface. While there
have been great strides in deciphering
the molecular basis of the disease, partic-
ularly in uncovering the proteolytic mech-
anisms that lead to the unraveling of
articular cartilage’s extracellular matrix,
progress in understanding the cellular
basis of disease has lagged behind. In
terms of cellular composition, Kouri et al.
used ultrastructural studies to show that
there are three cell types inhabiting osteo-
arthritic cartilage (Kouri et al., 1996). These
populations were designated type 1 cells,
which include singular and clustered
chondrocytes; type 2 elongated secretory
cells; and finally type 3 cells, irregularly
shaped chondrocytes undergoing various
stages of degeneration, such as pyknosis
(Figure 1B).
To date, the general focus of OA
research has concentrated on thesurviving chondrocyte-like type 1 cells, in
hopes of revealing the mechanisms
responsible for their transition to the
degenerative phenotype. The fibroblast-
like cells were initially considered to be
the product of dedifferentiation, as this
phenomenon has been extensively docu-
mented in vitro when chondrocytes are
passaged on tissue culture plastic.
Subsequently, it was demonstrated that
type 2 cells express a suite of proteins,
such as biglycan, decorin, perlecan, and
A
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Figure 1. Migratory Progenitors in Diseased
Articular Cartilage
(A) Healthy articular cartilage is composed of
superficial, transitional, and deep zones and one
mineralized layer, the calcified zone. The tidemark
constitutes the junction between the deep and
calcified zones. The distribution of proteoglycan,
a major component of the extracellular matrix
that is vital for normal function, is shown in red.
(B) Early phases of osteoarthritic disease are char-
acterized by superficial fissures and chondrocyte
clustering (through proliferation rather than migra-
tion). During the later phases of disease, fibrocarti-
lagenous repair tissue is observed (blue cells) with
greatly reduced proteoglycan content and there-
fore reduced biomechanical integrity. Diseased
tissue contains morphologically heterogeneous
populations of cells, some of which, elongated
and fibroblast-like (green cells), may have migrated
through breaks in the tidemark (arrowed) that coin-
cide with the appearance of neovascularisation in
this region (red). The terminal stages of disease
occur when fissuring extends through to the calci-
fied zone and subchondral plate leading to
massive cell death and tissue loss.Cell Stemcollagen type I, as an attempt, it is thought,
to compensate, stabilize, and restore
some biomechanical integrity to the de-
generating extracellular matrix through
the production of fibrocartilagenous repair
tissue (Tesche and Miosge, 2005). Intrigu-
ingly, type 2 cells are most frequent in
repair tissue that surrounds defects in
cartilage and also in locations at which
the normally intact border between the
calcified and deep zones, known as the
tidemark, is broken by neovascularisation
(Figure 1B). Based on these observations,
type 2 cells have been hypothesized to
represent interlopers that have been re-
cruited in an attempt to restore damaged
articular cartilage. Now, Miosge and
colleagues (Koelling et al., 2009) provide
evidence in support of this model.
In their study, the authors describe the
remarkable migratory potential of type 2
cells. This population can migrate from
intact human osteoarthritic cartilage onto
plastic, a property absent in cells from
normal healthy cartilage explants, and
conversely type 2 cells are also able to
migrate deep into osteoarthritic cartilage.
Further, Koelling et al. (2009) demonstrate
that type 2 or chondrogenic progenitor
cells (CPCs) could be cloned and
expanded for up to 60 population
doublings before the population becomes
senescent. CPCs express intermediate
levels of transcription factors runx2 and
sox9, indicating that they are likely
derived from the osteochondroprogenitor
lineage (Nakashima and de Crom-
brugghe, 2003). Koelling et al. demon-
strated the latter point by knocking
down runx2 expression using siRNA in
three-dimensional culture and witnessing
a doubling in sox9 expression levels and
comparable increases in chondrogenic
gene expression. This observation raises
an important question. That is, why do
type 2 cells retain their native phenotypic
state within osteoarthritic cartilage,
instead of differentiating into fully
committed chondrocytes? We can see
at least three explanations for this conun-
drum; the first, and most perhaps most
obvious, answer may be that differentia-
tion does in fact occur in OA tissue. One
could speculate that since the type 2 cells
are found surrounded by normal round
chondrocytes, it is possible that the
type 2 cells observed are still migrating
in response to chemoctactic signals and
have yet to receive a local differentiationCell 4, April 3, 2009 ª2009 Elsevier Inc. 283
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CPCs maintain their fibroblastic pheno-
type because by generating extracellular
proteins specific to this phenotype, the
structural and signaling cues delivered
by those products to the damaged extra-
cellular matrix and surrounding surviving
chondrocytes stimulate repair. Thirdly,
mindful that the cellular origins of type 2
cells are uncertain, it is possible that these
cells are unable to fully commit to the
chondrogenic lineage and are restricted
to a fibrocartilagenous phenotype that
provides temporary repair, which is ulti-
mately insufficient to heal diseased carti-
lage. All of these scenarios should be
easily testable via three-dimensional
coculture experiments.
Additionally, Koelling et al. (2009) have
shown that CPCs exhibit differential
responsiveness to runx2 knockdown that
is conditional on cell shape, whether
rounded when sox9 is upregulated, or
flat and spread out on plastic when sox9
expression remains unchanged. It is
known that mesenchymal stem cell
(MSC) differentiation to other lineages is
dependent in part upon local mechanical
cues embodied in cell shape, cytoskeletal
tension, and RhoA signaling (McBeath
et al., 2004). It is probable that CPC shape284 Cell Stem Cell 4, April 3, 2009 ª2009 Eland therefore chondrogenic capacity is
similarly modulated through compliance
to the mechanical forces and biomolec-
ular composition of the cells’ immediate
surroundings. We know from this group’s
previous work that a specific microenvi-
ronment is created in late-stage osteoar-
thritic tissue (Tesche and Miosge, 2005),
and, through other work, that RhoA
signaling that stimulates stress fiber
induction (and maintenance of the dedif-
ferentiated MSC phenotype) negatively
regulates chondrogenesis through reduc-
tion of sox9 expression and modulation of
cortical actin organization (Woods et al.,
2005). The interplay between these
various factors, biomechanical, extracel-
lular matrix, cytoskeletal, cellular, and
signaling, may broadly explain how repair
is initiated and maintained in osteoarthritic
cartilage by CPCs until other extrinsic
factors cause irreparable damage. The
true test of our understanding of this
system is to be able to manipulate CPCs
to fully commit to the chondrogenic
phenotype from a fibrocartilagenous
one, driving the process of repair and
regeneration to something approaching
maturity. There are clearly plenty of impor-
tant questions for the OA field to follow
up on, and one would do well to heed thesevier Inc.sage advice of William Hunter’s younger
brother John, who once advised a hesitant
Edward Jenner by simply saying, ‘‘But
why think? Why not try the experiment?’’
(Cameron, 1949).
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